CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for PAREXEL International Corporation is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

PAREXEL International Corporation
195 West St
Phone: (781) 487-9900p:781 487-9900 WALTHAM, MA  02451-1111  United States Fax: (781) 487-0525f:781 487-0525
This company was Merged or Acquired on 9/29/2017.
This company ceased filing statements with the SEC on 10/10/2017.
This company is no longer actively traded on any major stock exchange.
This is a Subsidiary, click here for the Parent Company
Business Summary
PAREXEL International Corporation (PAREXEL) is a biopharmaceutical outsourcing services company. The Company provides a range of expertise in clinical research, clinical logistics, medical communications, consulting, commercialization, and technology products and services to pharmaceutical, biotechnology and medical device industries. Its segments include Clinical Research Services (CRS) and AREXEL Consulting Services (PC). The CRS segment includes various phases of clinical research from first-in-man trials, where a medicinal entity is tested on human subjects for the first time, through post-marketing studies, following approval by the presiding regulatory body. The PC segment provides technical expertise and advice in areas, such as strategy, drug development, regulatory affairs, strategic compliance and targeted communications services in support of product launch.
(Source: 10-K)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
--YesYesYes--

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
--YesYes--Yes

Industries
SIC Code Description
8731 Commercial physical and biological research
8734 Testing laboratories
8999 Services, not elsewhere classified

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, Chief Executive Officer Josef H.von Rickenbach 61 7/1/2012 1/1/1983
President, Chief Operating Officer Mark A.Goldberg 62 7/1/2012 1/1/1997
Chief Financial Officer, Senior Vice President SimonHarford 6/1/2017 6/1/2017
12 additional Officers and Directors records available in full report.

Business Names
Business Name
BVUD Research (India) Private Limited
ClinIntel Limited
ClinPhone California Inc.
103 additional Business Names available in full report.

General Information
Stock Exchange: NASD
Federal Tax Id: 042776269
Fax Number: (781) 487-0525
Email Address: kate.mccorriston@parexel.com


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, March 29, 2024